Cage Bio Overview

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $11M

  • Investors
  • 7

Cage Bio General Information

Description

Developer of an eutectic ionic liquid designed to minimize the pervasive use of systemic drugs for the treatment of dermal diseases and symptoms. The company offers a product that is based on ionic liquid technology, which offers broad-spectrum antimicrobial and anti-inflammatory properties along with enhancement of solubility and permeability, enabling physicians to treat dermal diseases successfully and effectively using effective products for dermatology.

Contact Information

Website
www.cagebio.com
Formerly Known As
Ion Pair Bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 733 Industrial Road
  • San Carlos, CA 94070
  • United States
+1 (501)
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Drug Discovery
Vertical(s)
Corporate Office
  • 733 Industrial Road
  • San Carlos, CA 94070
  • United States
+1 (501)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cage Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 29-Apr-2025 $11M Completed Clinical Trials - Phase 2
6. Accelerator/Incubator Completed Clinical Trials - Phase 2
5. Early Stage VC (Series A2) 27-Oct-2021 Completed Clinical Trials - Phase 2
4. Early Stage VC (Series A) 16-Feb-2021 Completed Clinical Trials - Phase 2
3. Early Stage VC (Series B) 28-Jun-2019 Completed Clinical Trials - Phase 2
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator 05-Jul-2018 Completed Startup
To view Cage Bio’s complete valuation and funding history, request access »

Cage Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-2
Series B-1
Series A-3
Series A-2
Series A-1 3,838,471 $0.001000 $2.61 $2.61 1x $2.61 11.75%
Seed 1,845,541 $0.001000 $0.18 $0.18 1x $0.18 5.65%
To view Cage Bio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Cage Bio Patents

Cage Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4836784-A1 Topical compositions containing tofacitinib and ionic liquid Pending 07-Jan-2025
US-20260265761-A1 Topical compositions containing aptamer and ionic liquid Pending 18-Oct-2024
WO-2026085544-A1 Topical compositions containing aptamer and ionic liquid Pending 18-Oct-2024
AU-2025205671-A1 Topical compositions containing tofacitinib and ionic liquid Pending 07-Jan-2024
US-20260272822-A1 Topical compositions containing tofacitinib and ionic liquid Pending 07-Jan-2024 A61K9/0014
To view Cage Bio’s complete patent history, request access »

Cage Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cage Bio Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cowtown Angels Angel Group Minority
AG Collective Capital Venture Capital Minority
TexCag Corporation Minority
CKG Management Venture Capital Minority
Johnson & Johnson Innovation - JLABS Accelerator/Incubator
You’re viewing 5 of 7 investors. Get the full list »

Cage Bio FAQs

  • Where is Cage Bio headquartered?

    Cage Bio is headquartered in San Carlos, CA.

  • What is the size of Cage Bio?

    Cage Bio has 10 total employees.

  • What industry is Cage Bio in?

    Cage Bio’s primary industry is Biotechnology.

  • Is Cage Bio a private or public company?

    Cage Bio is a Private company.

  • What is Cage Bio’s current revenue?

    The current revenue for Cage Bio is .

  • How much funding has Cage Bio raised over time?

    Cage Bio has raised $57.6M.

  • Who are Cage Bio’s investors?

    Cowtown Angels, AG Collective Capital, TexCag, CKG Management, and Johnson & Johnson Innovation - JLABS are 5 of 7 investors who have invested in Cage Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process